Rous Sarcoma Virus (RSV) and Cancer
Abnormal Proliferation
Mechanisms of Retrovirus-induced Cancers
Non-LTR Retrotransposons
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: Sep 8, 2025

Isolation and Quantification of Epstein-Barr Virus from the P3HR1 Cell Line
Published on: September 28, 2022
Hua-Man Cai1, Yu-Ran Qiu1, Yun Tan1
1Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Mutations in RNA helicase DDX3X impair innate immunity and promote cancer by enabling Epstein-Barr virus (EBV) lytic gene BNLF2b. This leads to R-loop accumulation and genomic instability, offering new therapeutic targets.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: